- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2318
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Breast cancer in older woman: can axillary dissection be omitted? ; volume:9 ; number:1 ; day:1 ; month:4 ; year:2009 ; pages:1 ; date:4.2009
BMC geriatrics ; 9, Heft 1 (1.4.2009), 1, 4.2009
- Urheber
-
Barberini, Francesco
- Beteiligte Personen und Organisationen
-
Rulli, Antonio
Covarelli, Piero
Badolato, Marco
Gentile, Daniele
Boselli, Carlo
Rondelli, Fabio
Servoli, Alessandra
Noya, Giuseppe
SpringerLink (Online service)
- DOI
-
10.1186/1471-2318-9-S1-A17
- URN
-
urn:nbn:de:1111-2016021819662
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Barberini, Francesco
- Rulli, Antonio
- Covarelli, Piero
- Badolato, Marco
- Gentile, Daniele
- Boselli, Carlo
- Rondelli, Fabio
- Servoli, Alessandra
- Noya, Giuseppe
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Prospective Study of the Efficacy of Endofascial Axillary Dissection to Reduce Axillary Seroma Formation
Left axillary cannulation for acute type A aortic dissection
Postoperative peri-axillary seroma following axillary artery cannulation for surgical treatment of acute type A aortic dissection
Any woman can
Any woman can
Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial
Can Axillary Lymph Node Dissection Be Safely Omitted for Early-Stage Breast Cancer Patients with Sentinel Lymph Node Micrometastasis?
Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy
Axillary dissection versus axillary observation for low risk, clinically node-negative invasive breast cancer: a systematic review and meta-analysis
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
Combined femoral and axillary perfusion strategy for Stanford type a aortic dissection repair
A Prospective Study of the Efficacy of Endofascial Axillary Dissection to Reduce Axillary Seroma Formation
Left axillary cannulation for acute type A aortic dissection
Postoperative peri-axillary seroma following axillary artery cannulation for surgical treatment of acute type A aortic dissection
Any woman can
Any woman can
Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial
Can Axillary Lymph Node Dissection Be Safely Omitted for Early-Stage Breast Cancer Patients with Sentinel Lymph Node Micrometastasis?
Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy
Axillary dissection versus axillary observation for low risk, clinically node-negative invasive breast cancer: a systematic review and meta-analysis
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
Combined femoral and axillary perfusion strategy for Stanford type a aortic dissection repair
A Prospective Study of the Efficacy of Endofascial Axillary Dissection to Reduce Axillary Seroma Formation
Left axillary cannulation for acute type A aortic dissection
Postoperative peri-axillary seroma following axillary artery cannulation for surgical treatment of acute type A aortic dissection
Any woman can
Any woman can
Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial
Can Axillary Lymph Node Dissection Be Safely Omitted for Early-Stage Breast Cancer Patients with Sentinel Lymph Node Micrometastasis?
Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy
Axillary dissection versus axillary observation for low risk, clinically node-negative invasive breast cancer: a systematic review and meta-analysis
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial